Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418529 · ClinicalTrials.gov registry record
A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis
A clinical trial of Rheumatoid Arthritis, sponsored by Pfizer.
- Completed
- Registry status
- 21,340
- Enrollment target
- 1
- Study location
NCT06418529 is a study of Rheumatoid Arthritis that has completed, run by Pfizer. The registered enrollment target is 21,340 participants, above the 4,582-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (366% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06418529, a study of Rheumatoid Arthritis, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 21,340 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn how different types of medicines may improve disease activity in people with rheumatoid arthritis (RA). RA is a kind of joint disease that causes pain and swelling. The study will look at data from a large, US-based group of RA patients who have taken the below medicines: * Tofacitinib * Abatacept * Tocilizumab or sarilumab The study will compare clinical disease activity scores of patients on the different medicines taken. The study will also decide whether some patient traits or disease factors play a role in how medicines may improve disease activity.
Conditions Studied
Interventions
- DRUG abatacept
- DRUG tofacitinib
- DRUG tumor necrosis factor inhibitors (TNFi)
- DRUG tocilizumab or sarilumab
Study Locations (1)
New York
- Pfizer - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,340 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2024-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06418529
The ClinicalTrials.gov registry entry for NCT06418529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21,340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,582-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (366% higher). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 4 interventions - of which abatacept is the first listed.
NCT06418529 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06418529 about?
NCT06418529 is a clinical study titled "A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis". The purpose of this study is to learn how different types of medicines may improve disease activity in people with rheumatoid arthritis (RA). RA is a kind of joint disease that causes pain and swelling. The study will look at data from a large, US-based group of RA patients who have taken the below...
What is the current status of trial NCT06418529?
This trial is currently completed. The enrollment target is 21,340 participants. The study started on 2024-05-15. Estimated completion is 2024-07-19.
What conditions does trial NCT06418529 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis.
What interventions are being tested in trial NCT06418529?
The interventions under investigation include: abatacept (DRUG), tofacitinib (DRUG), tumor necrosis factor inhibitors (TNFi) (DRUG), tocilizumab or sarilumab (DRUG).
Who is sponsoring clinical trial NCT06418529?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06418529 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.